Document is current
Any future updates will be listed below
-
Authors
Zapata, J. Karina https://orcid.org/0000-0002-6008-6702
Gómez-Ambrosi, Javier https://orcid.org/0000-0001-5601-1604
Frühbeck, Gema https://orcid.org/0000-0002-8305-7154
-
Funding
Funding for this research was provided by:
Spanish Instituto de Salud Carlos III–Subdirección General de Evaluación y Fomento de la investigación–FEDER (PI20/00080, PI20/00927 and PI22/00745, PI20/00080, PI20/00927 and PI22/00745)
Gobierno de Navarra-FEDER and Dpt. of University, Innovation and Digital Transformation (PC098-099 MEPERTROBE)
Spanish Instituto de Salud Carlos III (CIBEROBN)
Universidad de Navarra
- License Information
-
More Information
Article History
Accepted: 18 March 2025
First Online: 7 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: JKZ and JGA declare no conflict of interest. GF declares research grants paid to the Institution from the Spanish Institute of Health ISCIII and payment of honoraria for lectures from Novo Nordisk as Member of the OPEN Spain Initiative as well as payment or honoraria for attendance to Advisory Boards from Lilly, Novo Nordisk, Regeneron and AstraZeneca.
